Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1092 | 1123 | 1212 | 1425 | 1825 | 3011 |
| Fund Return | 9.18% | 12.34% | 21.23% | 12.54% | 12.79% | 11.65% |
| Place in category | 21 | 40 | 43 | 6 | 5 | 4 |
| % in Category | 2 | 3 | 3 | 1 | 1 | 1 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| CM CIC Europe Growth C | 1.56B | 3.72 | 1.75 | 4.48 | ||
| CM-CIC Global Gold C | 680.99M | 33.63 | 56.83 | 18.75 | ||
| Flexigestion Patrimoine | 740.25M | 3.29 | 6.86 | 2.54 | ||
| CM CIC Equilibre International D | 665.34M | 3.49 | 9.64 | 4.41 | ||
| CM CIC Equilibre International C | 665.34M | 3.49 | 9.63 | 4.41 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Aviva Investors Conviction | 1.71B | 4.19 | 12.99 | 8.34 | ||
| Aviva Conviction Patrimoine | 1.53B | 3.95 | 11.34 | 6.75 | ||
| ALM Offensif | 1.13B | 2.54 | 9.30 | 7.33 | ||
| CPR Croissance Dynamique I | 736.93M | 2.40 | 11.79 | 7.90 | ||
| CPR Croissance Dynamique P | 736.93M | 2.28 | 10.94 | 7.13 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Exxon Mobil | US30231G1022 | 5.84 | 165.43 | +1.33% | |
| Union Moné Première | FR0010252635 | 5.62 | - | - | |
| Siemens AG | DE0007236101 | 5.20 | 209.75 | -0.97% | |
| Coca-Cola | US1912161007 | 5.15 | 74.69 | -0.74% | |
| EssilorLuxottica | FR0000121667 | 5.08 | 194.30 | -0.18% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review